IL15 and neoplasm: GPC3-targeting CAR-T cells with dual cytokine expression of IL-15 and IL-21 exhibited enhanced antitumour activity against HCC, demonstrating superior proliferation, persistence, and tumour regression in GPC3-positive xenograft models [146].